Cerebrovascular Involvement in Sickle Cell Disease - Comprehensive Sickle Cell Center
NCT00005326 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2016-03-16
Summary
To continue studies on the two major neurological complications of sickle cell disease (SCD): namely, stroke and chronic encephalopathy.
Conditions
- Anemia, Sickle Cell
- Blood Disease
- Cerebrovascular Accident
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
Darryl DeVivo · Columbia University
Eligibility
- Max Age
- 100 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1988-01-31
- Completion
- 2004-03-31
More Related Trials
-
Hemostasis in Sickle Cell Disease--Infancy to Adulthood
NCT00005703 ·Status: COMPLETED
-
Neurovascular Determinants of Cognitive Function in Adults With Sickle Cell Disease
NCT02946905 ·Status: COMPLETED
-
Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease
NCT00528801 ·Status: COMPLETED
-
Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
NCT05170412 ·Status: RECRUITING
-
Sickle Cell Disease: A Retrospective Chart Review
NCT01441375 ·Status: COMPLETED
-
Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study
NCT00850018 ·Status: COMPLETED ·Phase: PHASE1
-
Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait
NCT04349189 ·Status: COMPLETED
-
Establishing a Database of People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Data Project [C-Data])
NCT00529061 ·Status: TERMINATED
-
Metabolic and Hemodynamic Reserve in Pediatric SCA
NCT04406818 ·Status: RECRUITING ·Phase: NA
-
Cardiovascular Complications of Sickle Cell Disease
NCT01044901 ·Status: COMPLETED
-
The Afolabi Stroke Registry for Children and Young Adults With SCD in Northern Nigeria
NCT04800809 ·Status: COMPLETED
-
Parent Educational Program for Children With Sickle Cell Disease
NCT00860782 ·Status: COMPLETED ·Phase: NA
-
Stroke Prevention in Sickle Cell Anemia (STOP 1)
NCT00000592 ·Status: COMPLETED ·Phase: PHASE3
-
Minocycline In Neurocognitive Outcomes - Sickle Cell Disease
NCT05605366 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Pathophysiology of Acute Pain in Patients With Sickle Cell Disease
NCT03049475 ·Status: COMPLETED
-
Indices of Severity and Prognosis for Sickle Cell Disease
NCT00005467 ·Status: COMPLETED
-
Sickle Cell Clinical Research and Intervention Program
NCT02098863 ·Status: RECRUITING
-
Carbon Monoxide Levels and Sickle Cell Disease Severity
NCT01547793 ·Status: COMPLETED
-
Motivations, Expectations, and Decision-making of Sickle Cell Patients in Clinical Research
NCT03709303 ·Status: COMPLETED
-
Living With Sickle Cell Disease in the COVID-19 Pandemic
NCT04417673 ·Status: COMPLETED
-
Microvessels and Heart Problems in Sickle Cell Disease
NCT01602809 ·Status: COMPLETED
-
Blood Sampling for Research Related to Sickle Cell Disease
NCT00542230 ·Status: RECRUITING
-
Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease
NCT01389024 ·Status: COMPLETED ·Phase: PHASE2
-
Epidemiology of Silent and Overt Strokes in Sickle Cell Disease
NCT03376893 ·Status: ACTIVE_NOT_RECRUITING
-
Pain in Sickle Cell Epidemiologic Study
NCT00035763 ·Status: COMPLETED